[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100519559":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":7,"locations":7,"responsibleParty":8,"collaborators":7,"id":10,"slug":11,"hasResults":12,"nctId":13,"briefTitle":14,"officialTitle":15,"acronym":16,"eligibilityCriteria":17,"healthyVolunteers":12,"sex":18,"minAge":7,"maxAge":7,"enrollmentInfo":19,"targetDuration":7,"studyType":22,"phases":7,"briefSummary":23,"conditions":24,"keywords":31,"overallStatus":33,"whyStopped":7,"lastUpdateSubmitDate":34,"lastUpdatePostDateStruct":35,"startDateStruct":38,"completionDateStruct":39,"leadSponsor":41,"locationsCount":7},{"fullName":5,"class":6},"The First Hospital of Jilin University","OTHER",null,{"type":9,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100519559","pufas-in-preterm-infants-100519559",false,"NCT06045130","PUFAs in Preterm Infants","Characteristics of PUFAs Composition in Preterm Infants and Its Impact on Disease Prognosis","PIPI","Inclusion Criteria:\n\nInfants born between 24 and 36 weeks of gestational age who are admitted within 24 hours of birth, including both premature and full-term newborns.\n\n\\-\n\nExclusion Criteria:\n\nInfants with severe congenital developmental abnormalities, those requiring external supplementation of PUFAs in addition to standard intravenous nutrition and breastfeeding, and those with a severe prognosis indicating non-survival during their hospitalization.\n\n\\-","ALL",{"count":20,"type":21},600,"ESTIMATED","OBSERVATIONAL","The research endeavors to examine the critical composition of Polyunsaturated Fatty Acids (PUFAs) in premature infants across different gestational stages and under varying disease conditions, and delineate the metabolic attributes of PUFAs in premature infants and their interplay with the onset of diseases. This study anticipates furnishing a theoretical foundation for the rationalization of PUFAs supplementation in premature infants and for informing strategies related to disease prevention and management.",[25,26,27,28,29,30],"Necrotizing Enterocolitis","Intraventricular Hemorrhage","BPD - Bronchopulmonary Dysplasia","Sepsis","Periventricular Leukomalacia","Patent Ductus Arteriosus",[32],"PUFAs","NOT_YET_RECRUITING","2023-09-13",{"date":36,"type":37},"2023-09-21","ACTUAL",{"date":36,"type":21},{"date":40,"type":21},"2026-08-31",{"name":5,"class":6}]